[Therapeutic news of 1975].
D001729:Bismuth / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000188:drug therapy; D003975:Diazepam / Q000378:metabolism; D004358:Drug Therapy; D004700:Endocrine System Diseases / Q000188:drug therapy; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D005897:Glafenine / Q000009:adverse effects; D006505:Hepatitis / Q000378:metabolism; D006801:Humans; D006912:Hydroxyquinolines / Q000009:adverse effects; D006967:Hypersensitivity / Q000188:drug therapy; D007239:Infections / Q000628:therapy; D007674:Kidney Diseases / Q000139:chemically induced; D008659:Metabolic Diseases / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy; D009422:Nervous System Diseases / Q000139:chemically induced / Q000188:drug therapy; D011217:Practolol / Q000009:adverse effects; D012140:Respiratory Tract Diseases / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000188:drug therapy
D006912:Hydroxyquinolines; D005897:Glafenine; D003975:Diazepam; D011217:Practolol; D001729:Bismuth
Actualités thérapeutiques 1975